Slepian M J, Massia S P, Dehdashti B, Fritz A, Whitesell L
University Heart Center, University of Arizona, Tuscon 85724, USA.
Circulation. 1998 May 12;97(18):1818-27. doi: 10.1161/01.cir.97.18.1818.
Smooth muscle cell (SMC) migration is a vital component in the response of the arterial wall to revascularization injury. Cell surface integrin-extracellular matrix interactions are essential for cell migration. SMCs express both beta1- and beta3-integrins. In this study, we examined the relative functional roles of beta1- and beta3-integrin-matrix interactions in postinjury SMC migration.
Flow cytometry and fluorescence microscopy of migrating SMCs immunostained with anti-beta1 and anti-alpha(v)beta3/5 antibodies (Abs) revealed expression of both beta1- and beta3-integrins, with beta1 observed as linear streaks and beta3 found in focal contacts. In a scrape-wound migration assay, anti-beta1 Abs (92.0+/-10.7% of control, P=.1) and 0.5 mmol/L linear RGD (105+/-5% of control, P=.2) did not alter SMC migration at 48 hours after injury. Beta3-blockade, however, via Abs (anti-beta3/5 35.7+/-4.5% of control, anti-beta3 61+/-12% of control, both P<.001) and cyclic RGD (0.5 mmol/L) (12+/-10% of control, P<.001) decreased migration. Neither beta1- nor beta3-inhibition altered postinjury [3H]thymidine incorporation. In the rat carotid injury model, local adventitial polymer-based delivery of radiolabeled linear or cyclic RGD led to uptake and retention of label, for both peptides, over a 72-hour period after injury. Local arterial wall beta1-blockade via polymer-based delivery of linear RGD had no effect on SMC migration at 4.5 days (11.5+/-3.2 versus 12.8 SMCs per x600 field [control], P=.6) or on neointimal thickening at 14 days (I/M area ratio, 0.664+/-0.328 versus 1.179+/-0.324 [control], P=.6) after injury. In contrast, local beta3-blockade via cRGD limited migration (0.8+/-0.8 versus 12.8+/-4.4 SMCs per x600 field [control], P<.01) and thickening (I/M area ratio, 0.004+/-0.008 versus 1.179+/-0.324 [control], P<.01).
In postinjury migrating SMCs, beta3- rather than beta1-integrin-matrix interactions are of greater functional significance in adhesive processes essential for SMC migration in vitro and in vivo. Blockade of dominant SMC integrin (beta3)-matrix interactions may be a valuable approach for limiting injury-induced SMC migration and late arterial renarrowing.
平滑肌细胞(SMC)迁移是动脉壁对血管再通损伤反应的重要组成部分。细胞表面整合素-细胞外基质相互作用对细胞迁移至关重要。平滑肌细胞同时表达β1和β3整合素。在本研究中,我们检测了β1和β3整合素-基质相互作用在损伤后平滑肌细胞迁移中的相对功能作用。
用抗β1和抗α(v)β3/5抗体(Abs)免疫染色的迁移平滑肌细胞的流式细胞术和荧光显微镜检查显示β1和β3整合素均有表达,β1呈线性条纹状,β3见于粘着斑。在划痕损伤迁移试验中,抗β1抗体(为对照的92.0±10.7%,P = 0.1)和0.5 mmol/L线性RGD(为对照的105±5%,P = 0.2)在损伤后48小时未改变平滑肌细胞迁移。然而,通过抗体(抗β3/5为对照的35.7±4.5%,抗β3为对照的61±12%,均P<0.001)和环RGD(0.5 mmol/L)(为对照的12±10%,P<0.001)阻断β3可减少迁移。β1或β3抑制均未改变损伤后[3H]胸腺嘧啶核苷掺入。在大鼠颈动脉损伤模型中,损伤后72小时内,基于聚合物的局部外膜放射性标记线性或环RGD递送导致两种肽的标记摄取和保留。基于聚合物的线性RGD局部动脉壁β1阻断在损伤后4.5天对平滑肌细胞迁移(每x600视野11.5±3.2对12.8个平滑肌细胞[对照],P = 0.6)或14天内膜增厚(I/M面积比,0.664±0.328对1.179±0.324[对照],P = 0.6)无影响。相反,通过cRGD进行局部β3阻断限制了迁移(每x600视野0.8±0.8对12.8±4.4个平滑肌细胞[对照],P<0.01)和增厚(I/M面积比,0.004±0.008对1.179±0.324[对照],P<0.01)。
在损伤后迁移的平滑肌细胞中,β3而非β1整合素-基质相互作用在体外和体内平滑肌细胞迁移所必需的粘附过程中具有更大的功能意义。阻断主要的平滑肌细胞整合素(β3)-基质相互作用可能是限制损伤诱导的平滑肌细胞迁移和晚期动脉再狭窄的一种有价值的方法。